**Question:** Beta lactamase resistant penicillin:

A. Ceftriaxone
B. Amoxicillin-clavulanic acid
C. Cephalosporins
D. Carbapenems

**Correct Answer:** B. Amoxicillin-clavulanic acid

**Core Concept:**
Beta-lactamases are enzymes produced by bacteria that can break down beta-lactam antibiotics, rendering them ineffective. Beta-lactamase inhibitors, such as clavulanic acid, are used in combination with beta-lactam antibiotics to protect them from being inactivated by these enzymes.

**Why the Correct Answer is Right:**
Amoxicillin-clavulanic acid is a combination antibiotic and beta-lactamase inhibitor. Amoxicillin is a penicillin-type antibiotic that is susceptible to beta-lactamase degradation. Clavulanic acid is a beta-lactamase inhibitor that prevents the breakdown of amoxicillin by beta-lactamases, making the combination effective against susceptible bacteria.

**Why Each Wrong Option is Incorrect:**

A. Ceftriaxone (Cephalosporin): Ceftriaxone is a beta-lactam antibiotic, but it is not susceptible to beta-lactamase degradation. It is a broad-spectrum antibiotic with activity against gram-positive and gram-negative bacteria.

B. Amoxicillin alone: As mentioned earlier, beta-lactamases can degrade amoxicillin, rendering it ineffective. Clavulanic acid in combination with amoxicillin protects it from degradation.

C. Cephalosporins: Cephalosporins are a class of beta-lactam antibiotics, but they are susceptible to beta-lactamase degradation. This option is incorrect because it is a broad-spectrum antibiotic like ceftriaxone, not a beta-lactamase inhibitor.

D. Carbapenems: Carbapenems are a class of broad-spectrum beta-lactam antibiotics, but they are resistant to beta-lactamase degradation. This option is incorrect because it is a different class of antibiotic with unique properties, not a combination therapy.

**Clinical Pearl:**
Beta-lactamase inhibitors like clavulanic acid are essential for the successful use of beta-lactam antibiotics against beta-lactamase-producing bacteria. By combining a beta-lactamase-sensitive antibiotic, like amoxicillin, with a beta-lactamase inhibitor, like clavulanic acid, we protect the antibiotic from degradation and maintain its efficacy against beta-lactamase-producing bacteria. This combination therapy is particularly useful in treating infections caused by beta-lactamase-producing bacteria.